These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 1559308

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.
    Yukawa M, Yukawa E, Suematsu F, Takiguchi T, Ikeda H, Aki H, Mimemoto M.
    Drugs Aging; 2011 Oct 01; 28(10):831-41. PubMed ID: 21970310
    [Abstract] [Full Text] [Related]

  • 4. Direct comparison of three methods for predicting digoxin concentrations.
    Williams PJ, Lane JR, Capparelli EV, Kim YH, Coleman R.
    Pharmacotherapy; 1996 Oct 01; 16(6):1085-92. PubMed ID: 8947982
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications.
    Doering W.
    N Engl J Med; 1979 Aug 23; 301(8):400-4. PubMed ID: 460341
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
    Yukawa E, Suematu F, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y, Aoyama T.
    Clin Pharmacokinet; 2001 Aug 23; 40(10):773-81. PubMed ID: 11707062
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.
    Yukawa E, Mine H, Higuchi S, Aoyama T.
    J Pharm Pharmacol; 1992 Sep 23; 44(9):761-5. PubMed ID: 1360530
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E, Akiyama K, Suematsu F, Yukawa M, Minemoto M.
    J Clin Pharm Ther; 2007 Aug 23; 32(4):381-6. PubMed ID: 17635340
    [Abstract] [Full Text] [Related]

  • 13. Altered absorption of digoxin, sustained-release quinidine, and warfarin with sucralfate administration.
    Rey AM, Gums JG.
    DICP; 1991 Aug 23; 25(7-8):745-6. PubMed ID: 1949932
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T.
    J Clin Pharmacol; 1997 Feb 23; 37(2):92-100. PubMed ID: 9055134
    [Abstract] [Full Text] [Related]

  • 17. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?
    el-Desoky ES, Madabushi R, Amry Sel-D, Bhattaram VA, Derendorf H.
    Am J Ther; 2005 Feb 23; 12(4):320-7. PubMed ID: 16041195
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.